23.59
0.59%
-0.14
After Hours:
23.59
Phibro Animal Health Corp stock is traded at $23.59, with a volume of 96,943.
It is down -0.59% in the last 24 hours and up +0.68% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$23.73
Open:
$23.59
24h Volume:
96,943
Relative Volume:
0.50
Market Cap:
$955.08M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
28.77
EPS:
0.82
Net Cash Flow:
$37.02M
1W Performance:
+0.86%
1M Performance:
+0.68%
6M Performance:
+27.17%
1Y Performance:
+127.92%
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
23.59 | 955.08M | 982.01M | 14.80M | 37.02M | 0.82 |
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-10-24 | Initiated | JP Morgan | Neutral |
Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
Dec-21-22 | Initiated | ROTH Capital | Buy |
Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
Aug-05-21 | Resumed | Credit Suisse | Neutral |
Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
Jun-11-19 | Initiated | Barclays | Underweight |
May-23-19 | Initiated | Guggenheim | Neutral |
May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
Aug-23-17 | Resumed | BofA/Merrill | Underperform |
Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
Dec-15-16 | Initiated | Piper Jaffray | Overweight |
Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
Apr-11-16 | Reiterated | Guggenheim | Buy |
Feb-04-16 | Initiated | Credit Suisse | Outperform |
Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
Sep-30-15 | Initiated | Gabelli & Co | Buy |
Apr-24-15 | Reiterated | Barclays | Overweight |
Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
PAHC (Phibro Animal Health) 5-Year Dividend Growth Rate : 0.60% (As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Free Cash Flow per Share : $1.00 (TTM As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Effective Interest Rate on Debt % : 6.30% (As of Sep. 2024) - GuruFocus.com
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance Australia
PAHC (Phibro Animal Health) EPS without NRI : $1.40 (TTM As of Sep. 2024) - GuruFocus.com
Zacks Research Has Pessimistic Outlook of PAHC Q3 Earnings - MarketBeat
PAHC (Phibro Animal Health) 50-Day SMA : $23.16 (As of Nov. 24, 2024) - GuruFocus.com
Atria Investments Inc Has $283,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
PAHC (Phibro Animal Health) FCF Margin % : 1.17% (As of Sep. 2024) - GuruFocus.com
Zacks Research Has Pessimistic Outlook of PAHC Q2 Earnings - MarketBeat
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Lowered to Buy Rating by StockNews.com - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12 - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Gap Down to $24.34 on No - GuruFocus.com
Phibro Animal Health Corporation Updates Standalone Financial Guidance for Fiscal Year Ending June 30, 2025 and Provides Preliminary Financial Guidance for the Eight Months in Fiscal Year 2025 - Marketscreener.com
There May Be Some Bright Spots In Phibro Animal Health's (NASDAQ:PAHC) Earnings - Yahoo Finance
Phibro Animal Health Corporation Announces Executive Changes - Marketscreener.com
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice - Yahoo Finance
Barclays Issues Positive Forecast for Phibro Animal Health (NASDAQ:PAHC) Stock Price - MarketBeat
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Phibro Anim stock soars to 52-week high, hits $25.2 By Investing.com - Investing.com South Africa
Phibro Anim stock soars to 52-week high, hits $25.2 - Investing.com
Investing in Phibro (PAHC)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) Q1 2025 Earnings Call Transcript - Insider Monkey
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Phibro Animal Health First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Acquisitions - GuruFocus.com
Phibro Animal Health Corp (PAHC) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance UK
Phibro Animal Health Reports Strong Q1 Performance - TipRanks
Phibro Animal Health Co. (NASDAQ:PAHC) to Issue Quarterly Dividend of $0.12 - MarketBeat
Phibro's Q1 Earnings Top Estimates, Stock Up, Net Sales Surge Y/Y - Yahoo Finance Australia
Zacks.com featured highlights include IAMGOLD, Leidos, Brinker International, Phibro Animal Health and State Street - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q1 Earnings: EPS of $0.17 Beats Estimates, Revenue Surges to $260.4 Million - GuruFocus.com
Phibro: Fiscal Q1 Earnings Snapshot - San Francisco Chronicle
Phibro Animal Health (PAHC) Tops Q1 Earnings Estimates - Yahoo Finance
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance - StockTitan
Phibro Animal Health Corporation Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com
What To Expect From Phibro Animal Health Corp (PAHC) Q1 2025 Ear - GuruFocus.com
What To Expect From Phibro Animal Health Corp (PAHC) Q1 2025 Earnings - Yahoo Finance
Phibro Animal Health Corporation Declares Quarterly Dividend - StockTitan
Phibro announces quarterly dividend of $0.12 per share - Investing.com
What's Next: Phibro Animal Health's Earnings Preview - Benzinga
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q1 2025 Earnings Report Preview: What to Expect - GuruFocus.com
Vanguard Group Inc's Strategic Acquisition in Phibro Animal Heal - GuruFocus.com
Should We Be Cautious About Phibro Animal Health Corporation's (NASDAQ:PAHC) ROE Of 0.9%? - Yahoo Finance
Phibro completes acquisition of Zoetis’ medicated feed additive business - FeedStrategy.com
PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis - Yahoo Finance
Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products - Yahoo Finance
Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Phibro Animal Health (PAHC) Set to Announce Earnings on Wednesday - MarketBeat
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):